Condition
Coagulation Disorder clinical trials and research
As of November 12, 2026, Find a Trial lists 7 Coagulation Disorder clinical trials that are recruiting, at sites in 26 countries (most in Canada (3), United States (3), Netherlands (2)). By phase: Phase 3 (2), Phase 4 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 7Clinical trials
- 26Countries
Newest Coagulation Disorder clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Reltodecacog alfa plus usual care in adults needing urgent surgery while on a FXa DOAC | Phase 3 | Chandler, Arizona and 76 other locations | Recruiting | Dec 17, 2025 |
| Reducing postpartum blood loss with coagulation factor XIII | Phase 4 | Geneva, Canton of Geneva and 8 other locations | Recruiting | Jul 1, 2024 |
| Predicting stroke risk using extracellular vesicles in TIA patients | — | Merthyr Tydfil | Recruiting | Dec 9, 2022 |
| Using TAK-330 to reverse blood thinning effects for urgent surgeries | Phase 3 | Arkansas City, Arkansas and 63 other locations | Recruiting | Dec 14, 2021 |
| Comparing patients with and without endocarditis undergoing valve surgery | — | Amsterdam, North Holland | Recruiting | Dec 1, 2021 |
| Assessing blood clotting disorders in traumatic brain injury patients | — | Shanghai | Recruiting | Aug 24, 2020 |
| Understanding how drugs work in children | — | Phoenix, Arizona and 51 other locations | Recruiting | Feb 20, 2020 |
All recruiting trials (7)
-
Reltodecacog alfa plus usual care in adults needing urgent surgery while on a FXa DOAC
Aims to see if reltodecacog alfa can help blood clot faster during urgent surgery in adults taking FXa DOACs, compared with the usual care.
-
Reducing postpartum blood loss with coagulation factor XIII
This study is testing if giving a treatment called coagulation factor XIII can help reduce heavy bleeding after childbirth in women who have had a vaginal delivery.
-
Predicting stroke risk using extracellular vesicles in TIA patients
This study is trying to see if certain tiny particles in the blood can help predict which patients who have had a Transient Ischemic Attack (TIA) are at higher risk for having a stroke later on.
-
Using TAK-330 to reverse blood thinning effects for urgent surgeries
This study is testing if a new drug called TAK-330 can work better than a standard treatment to reverse blood thinning effects for adults who need urgent surgery.
-
Comparing patients with and without endocarditis undergoing valve surgery
This study looks at how patients with and without endocarditis do during heart valve surgery to see if their treatment and recovery needs are different.
-
Assessing blood clotting disorders in traumatic brain injury patients
This study is trying to see how blood clotting problems in people with traumatic brain injuries affect their recovery and outcomes after they arrive at the hospital.
-
Understanding how drugs work in children
This study is trying to find the best and safest doses of certain medications for children and young adults under 21 who are being treated for conditions like COVID-19 and pulmonary arterial hypertension.
Related topics
Quick answers
How many Coagulation Disorder clinical trials are recruiting right now?
7, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 26 countries. The most sites are in Canada (3 trials), United States (3 trials), Netherlands (2 trials), United Kingdom (2 trials), Austria (2 trials). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 3: 2, Phase 4: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.